Dianthus Therapeutics, Inc. /DE/ Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent
Dianthus Therapeutics, Inc. /DE/ (DNTH) reported Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent of -$1.55 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent · last filed 2026-08-04
- Dianthus Therapeutics, Inc. /DE/ other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2026-06-30 was -$1.55M.
- Dianthus Therapeutics, Inc. /DE/ other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2026-03-31 was -$1.06M, a 748.78% decline year-over-year.
- Dianthus Therapeutics, Inc. /DE/ other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2025-12-31 was $326.00K.
- Dianthus Therapeutics, Inc. /DE/ other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2025-09-30 was $65.00K, a 90.95% decline year-over-year.
- Dianthus Therapeutics, Inc. /DE/ other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2025 was $383.00K, a 549.15% increase from fiscal 2024.
- Dianthus Therapeutics, Inc. /DE/ other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2024 was $59.00K, a 71.63% decline from fiscal 2023.
- Dianthus Therapeutics, Inc. /DE/ other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2023 was $208.00K.
- Dianthus Therapeutics, Inc. /DE/ other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2022 was -$161.00K.
| Period end | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 3 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 3 month as first filed | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 6 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 6 month as first filed | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 9 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 9 month as first filed | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 12 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$1.55M 10-Q · filed 2026-08-04 | -$2.62M 10-Q · filed 2026-08-04 | -$2.29M derived: sum of 3 quarters · filed 2026-08-04 | -$2.23M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2026-03-31 | -$1.06M 10-Q · filed 2026-05-05 | -$738.00K derived: sum of 2 quarters · filed 2026-05-05 | -$673.00K derived: sum of 3 quarters · filed 2026-05-05 | -$845.00K derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-12-31 | $326.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | $391.00K derived: sum of 2 quarters · filed 2026-03-09 | $219.00K derived: sum of 3 quarters · filed 2026-08-04 | $383.00K 10-K · filed 2026-03-09 | ||||
| 2025-09-30 | $65.00K 10-Q · filed 2025-11-05 | -$107.00K derived: sum of 2 quarters · filed 2026-08-04 | $57.00K 10-Q · filed 2025-11-05 | -$518.00K derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-06-30 | -$172.00K 10-Q · filed 2026-08-04 | -$8.00K 10-Q · filed 2026-08-04 | -$583.00K derived: sum of 3 quarters · filed 2026-08-04 | $135.00K derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-03-31 | $164.00K 10-Q · filed 2026-05-05 | -$411.00K derived: sum of 2 quarters · filed 2026-05-05 | $307.00K derived: sum of 3 quarters · filed 2026-05-05 | $297.00K derived: sum of 4 quarters · filed 2026-05-05 | ||||
| 2024-12-31 | -$575.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | $143.00K derived: sum of 2 quarters · filed 2026-03-09 | $133.00K derived: sum of 3 quarters · filed 2026-03-09 | $59.00K 10-K · filed 2026-03-09 | ||||
| 2024-09-30 | $718.00K 10-Q · filed 2025-11-05 | $708.00K derived: sum of 2 quarters · filed 2025-11-05 | $634.00K 10-Q · filed 2025-11-05 | $685.00K derived: sum of 4 quarters · filed 2025-11-05 | ||||
| 2024-06-30 | -$10.00K 10-Q · filed 2025-08-07 | -$84.00K 10-Q · filed 2025-08-07 | -$33.00K derived: sum of 3 quarters · filed 2025-08-07 | -$18.00K derived: sum of 4 quarters · filed 2025-08-07 | ||||
| 2024-03-31 | -$74.00K 10-Q · filed 2025-05-12 | -$23.00K derived: sum of 2 quarters · filed 2025-05-12 | -$8.00K derived: sum of 3 quarters · filed 2025-05-12 | $30.00K derived: sum of 4 quarters · filed 2025-05-12 | ||||
| 2023-12-31 | $51.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-11 | $66.00K derived: sum of 2 quarters · filed 2025-03-11 | $104.00K derived: sum of 3 quarters · filed 2025-03-11 | $208.00K 10-K · filed 2025-03-11 | ||||
| 2023-09-30 | $15.00K 10-Q · filed 2024-11-07 | $53.00K derived: sum of 2 quarters · filed 2024-11-07 | $157.00K 10-Q · filed 2024-11-07 | $146.00K derived: sum of 4 quarters · filed 2024-11-07 | ||||
| 2023-06-30 | $38.00K 10-Q · filed 2024-08-08 | $13.00K 10-Q · filed 2023-08-03 | $142.00K 10-Q · filed 2024-08-08 | $178.00K 10-Q · filed 2023-08-03 | $131.00K derived: sum of 3 quarters · filed 2024-08-08 | -$19.00K derived: sum of 4 quarters · filed 2024-08-08 | ||
| 2023-03-31 | $104.00K 10-Q · filed 2024-05-09 | $165.00K 10-Q · filed 2023-05-15 | $93.00K derived: sum of 2 quarters · filed 2024-05-09 | -$57.00K derived: sum of 3 quarters · filed 2024-05-09 | -$190.00K derived: sum of 4 quarters · filed 2024-05-09 | |||
| 2022-12-31 | -$11.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-21 | -$161.00K derived: sum of 2 quarters · filed 2024-03-21 | -$294.00K derived: sum of 3 quarters · filed 2024-03-21 | -$161.00K 10-K · filed 2024-03-21 | -$151.00K 10-K · filed 2023-03-23 | |||
| 2022-09-30 | -$150.00K 10-Q · filed 2023-11-09 | $140.00K 10-Q · filed 2022-11-03 | -$283.00K derived: sum of 2 quarters · filed 2023-11-09 | -$150.00K 10-Q · filed 2023-11-09 | -$432.00K 10-Q · filed 2022-11-03 | -$746.00K derived: sum of 4 quarters · filed 2023-12-21 | ||
| 2022-06-30 | -$133.00K 10-Q · filed 2023-08-03 | -$572.00K 10-Q · filed 2023-08-03 | -$596.00K derived: sum of 3 quarters · filed 2023-12-21 | -$597.00K derived: sum of 4 quarters · filed 2023-12-21 | ||||
| 2022-03-31 | -$439.00K 10-Q · filed 2023-05-15 | -$463.00K derived: sum of 2 quarters · filed 2023-12-21 | -$464.00K derived: sum of 3 quarters · filed 2023-12-21 | -$471.00K derived: sum of 4 quarters · filed 2023-12-21 | ||||
| 2021-12-31 | -$24.00K derived: 8-K 12 month − 10-Q 9 month · filed 2023-12-21 | -$25.00K derived: sum of 2 quarters · filed 2023-12-21 | -$32.00K derived: sum of 3 quarters · filed 2023-12-21 | $0.00 8-K · filed 2023-12-21 | -$7.00K 10-K · filed 2022-03-08 | |||
| 2021-09-30 | -$1.00K 10-Q · filed 2022-11-03 | -$8.00K derived: sum of 2 quarters · filed 2022-11-03 | $24.00K 10-Q · filed 2022-11-03 | -$38.00K derived: sum of 4 quarters · filed 2022-11-03 | ||||
| 2021-06-30 | -$7.00K 10-Q · filed 2022-08-04 | $25.00K 10-Q · filed 2022-08-04 | -$37.00K derived: sum of 3 quarters · filed 2022-08-04 | -$151.00K derived: sum of 4 quarters · filed 2022-08-04 | ||||
| 2021-03-31 | $32.00K 10-Q · filed 2022-05-16 | -$30.00K derived: sum of 2 quarters · filed 2022-05-16 | -$144.00K derived: sum of 3 quarters · filed 2022-05-16 | -$354.00K derived: sum of 4 quarters · filed 2022-05-16 | ||||
| 2020-12-31 | -$62.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-08 | -$176.00K derived: sum of 2 quarters · filed 2022-03-08 | -$386.00K derived: sum of 3 quarters · filed 2022-03-08 | -$31.00K 10-K · filed 2022-03-08 | ||||
| 2020-09-30 | -$114.00K 10-Q · filed 2021-11-04 | -$324.00K derived: sum of 2 quarters · filed 2021-11-04 | $31.00K 10-Q · filed 2021-11-04 | -$44.00K derived: sum of 4 quarters · filed 2021-11-04 | ||||
| 2020-06-30 | -$210.00K 10-Q · filed 2021-08-05 | $145.00K 10-Q · filed 2021-08-05 | $70.00K derived: sum of 3 quarters · filed 2021-08-05 | $14.00K derived: sum of 4 quarters · filed 2021-08-05 | ||||
| 2020-03-31 | $355.00K 10-Q · filed 2021-05-06 | $280.00K derived: sum of 2 quarters · filed 2021-05-06 | $224.00K derived: sum of 3 quarters · filed 2021-05-06 | $322.00K derived: sum of 4 quarters · filed 2021-05-06 | ||||
| 2019-12-31 | -$75.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-03 | -$131.00K derived: sum of 2 quarters · filed 2021-03-03 | -$33.00K derived: sum of 3 quarters · filed 2021-03-03 | $16.00K 10-K · filed 2021-03-03 | ||||
| 2019-09-30 | -$56.00K 10-Q · filed 2020-11-05 | $42.00K derived: sum of 2 quarters · filed 2020-11-05 | $91.00K 10-Q · filed 2020-11-05 | |||||
| 2019-06-30 | $98.00K 10-Q · filed 2020-08-06 | $147.00K 10-Q · filed 2020-08-06 | ||||||
| 2019-03-31 | $49.00K 10-Q · filed 2020-05-07 | |||||||
| 2018-12-31 | -$8.00K 10-K · filed 2020-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
| Veradermics, Inc (MANE) | United States | $4.839B | |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Edgewise Therapeutics, Inc. (EWTX) | United States | $4.470B | -22.23 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Viking Therapeutics, Inc. (VKTX) | United States | $4.287B | -8.51 |